2 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Sage Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor SAGE-324 - Essential Tremor | Phase 2 / Phase 3 | Terminated | Sage Therapeutics | 97 | 2022-06-03 | 2025-08-01 |
| A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19) Brexanolone, Placebo - Acute Respiratory Distress Syndrome, COVID-19 | Phase 3 | Terminated | Sage Therapeutics | 29 | 2020-12-18 | 2022-08-19 |
COVID-19 (1) · Essential Tremor (1) · Respiratory Distress Syndrome (1)
Pregnanolone (1) · brexanolone (1)
United States (2)